Doximity, Inc.

DOCS Healthcare Health Information Services

Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025. In the quarter to June 2026, revenue grew 7.34%, EPS fell 53.6% and free cash flow fell 34.1%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for five.

30.97 0.53 −1.68%
Market cap
$5.6B
P/E
34.8×
Fwd P/E
26.2×
Dividend yield
—
F-score
5/9
Altman Z
17.11
Beneish M
−2.93
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

54.59 34.87 22.40 23.30
P/S ratio
22.10 13.02 6.76 5.78
P/FCF ratio
43.99 27.02 13.72 12.75
P/Operating CF
146.16 136.33 39.79 90.18
P/B ratio
12.53 8.48 4.58 4.13
EV/Sales
20.69 11.86 5.60 4.73
EV/EBITDA
49.52 29.65 15.34 14.20
EV/FCF
41.18 24.62 11.36 10.43
Current Ratio
7.79 6.63 6.09 6.08
Net Debt/EBITDA
(12.95) (9.59) (23.37) (16.51)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
1.83% 2.87% 4.46% 4.29%
Free Cash Flow Yield
2.27% 3.70% 7.29% 7.84%
Free Cash Flow per Share
0.49 0.31 0.57 0.22
Book value per Share
5.84 5.22 5.08 5.02
Free Cash Flow
91.58 58.52 107.27 39.60
EV/EBIT
52.07 31.69 16.79 15.97
Other line items

Show all line items

Columns are period end dates